Proteomics Intl Labs Ltd has released a press release.
Chinese patent granted for OxiDx technology
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Story so far
Earlier from Proteomics International Laboratories
- Share Purchase Plan Offer Booklet
- $4.5m placement to launch Promarker diagnostics
- Trading Halt
- Pause in Trading
- Australian patent granted for OxiDx oxidative stress test
Later from Proteomics International Laboratories
- PromarkerEndo latest results presented at world congress
- $12 million capital raise completed with oversubscribed SPP
- A landmark in non-invasive Esophageal Cancer diagnosis
- Supplementary Prospectus
- PromarkerD launched into the US at major diabetes conference
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories